Literature DB >> 27312023

213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015.

Olivier Benveniste1, Lisa G Rider2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27312023      PMCID： PMC5118225          DOI： 10.1016/j.nmd.2016.05.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  97 in total

1.  Unicorns, dragons, polymyositis, and other mythological beasts.

Authors:  Anthony A Amato; Robert C Griggs
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

Review 2.  Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL).

Authors:  Lucy Busija; Eva Pausenberger; Terry P Haines; Sharon Haymes; Rachelle Buchbinder; Richard H Osborne
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

3.  Long-term observational study of sporadic inclusion body myositis.

Authors:  Olivier Benveniste; Marguerite Guiguet; Jane Freebody; Odile Dubourg; Waney Squier; Thierry Maisonobe; Tanya Stojkovic; Maria Isabel Leite; Yves Allenbach; Serge Herson; Stefen Brady; Bruno Eymard; David Hilton-Jones
Journal:  Brain       Date:  2011-10-12       Impact factor: 13.501

4.  Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy.

Authors:  Kerry B Stone; Chester V Oddis; Noreen Fertig; Yasuhiro Katsumata; Mary Lucas; Molly Vogt; Robyn Domsic; Dana P Ascherman
Journal:  Arthritis Rheum       Date:  2007-09

5.  Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.

Authors:  R Q Klein; C A Bangert; M Costner; M K Connolly; A Tanikawa; J Okawa; M Rose; S S Fakharzadeh; D Fiorentino; L A Lee; R D Sontheimer; L Taylor; A B Troxel; V P Werth
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

6.  Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.

Authors:  Nicolino Ruperto; Angela Pistorio; Sheila Oliveira; Francesco Zulian; Ruben Cuttica; Angelo Ravelli; Michel Fischbach; Bo Magnusson; Gary Sterba; Tadej Avcin; Karine Brochard; Fabrizia Corona; Frank Dressler; Valeria Gerloni; Maria T Apaz; Claudia Bracaglia; Adriana Cespedes-Cruz; Rolando Cimaz; Gerard Couillault; Rik Joos; Pierre Quartier; Ricardo Russo; Marc Tardieu; Nico Wulffraat; Blanca Bica; Pavla Dolezalova; Virginia Ferriani; Berit Flato; Ana G Bernard-Medina; Troels Herlin; Maria Trachana; Antonella Meini; Emma Allain-Launay; Clarissa Pilkington; Veronika Vargova; Carine Wouters; Simona Angioloni; Alberto Martini
Journal:  Lancet       Date:  2015-11-30       Impact factor: 79.321

7.  Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.

Authors:  Adam M Huber; Elizabeth M Dugan; Peter A Lachenbruch; Brian M Feldman; Maria D Perez; Lawrence S Zemel; Carol B Lindsley; Robert M Rennebohm; Carol A Wallace; Murray H Passo; Ann M Reed; Suzanne L Bowyer; Susan H Ballinger; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2008-02-15

8.  Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.

Authors:  Helga Sanner; Ivar Sjaastad; Berit Flatø
Journal:  Rheumatology (Oxford)       Date:  2014-03-31       Impact factor: 7.580

Review 9.  Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken.

Authors:  Olivier Benveniste; Werner Stenzel; David Hilton-Jones; Marco Sandri; Olivier Boyer; Baziel G M van Engelen
Journal:  Acta Neuropathol       Date:  2015-01-13       Impact factor: 17.088

10.  Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.

Authors:  Jessie Aouizerate; Marie De Antonio; Guillaume Bassez; Romain K Gherardi; Francis Berenbaum; Loïc Guillevin; Alice Berezne; Dominique Valeyre; Thierry Maisonobe; Odile Dubourg; Anne Cosnes; Olivier Benveniste; François Jérôme Authier
Journal:  Acta Neuropathol Commun       Date:  2014-10-23       Impact factor: 7.801
View more
  4 in total

Review 1.  Update on outcome assessment in myositis.

Authors:  Lisa G Rider; Rohit Aggarwal; Pedro M Machado; Jean-Yves Hogrel; Ann M Reed; Lisa Christopher-Stine; Nicolino Ruperto
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

2.  Predictors of Reduced Health-Related Quality of Life in Adult Patients With Idiopathic Inflammatory Myopathies.

Authors:  Michal Feldon; Payam Noroozi Farhadi; Hermine I Brunner; Lukasz Itert; Bob Goldberg; Abdullah Faiq; Jesse Wilkerson; Kathryn M Rose; Lisa G Rider; Frederick W Miller; Edward H Giannini
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

3.  Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.

Authors:  Hongya Zhang; Fangyuan He; Ming Shi; Wenxiu Wang; Xiaojia Tian; Juan Kang; Wenjuan Han; Rui Wu; Linfu Zhou; Mengmeng Hu; Xiaobo Li; Fang Mi; Gang Zhao; Hongge Jia
Journal:  Front Neurol       Date:  2017-04-12       Impact factor: 4.003

4.  Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.

Authors:  Minoesch Min; Anne W Walter; Johan Lim; Filip Eftimov; Camiel Verhamme; Marianne de Visser; Ivo N van Schaik; Rohit Aggarwal; Rob J de Haan; Anneke J van der Kooi; Joost Raaphorst
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.